QUOTE AND NEWS
StreetInsider.com  Jun 23 
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/Symmetry+Medical+%28SMA%29+Appoints+Craig+Reynolds+as+Chairman+of+the+Board+/4750307.html for the full story.
PR News Wire  May 7 
Reaffirms Full Year 2009 Revenue and Increases Low-end of EPS Guidance WARSAW, Ind., May 7 /PRNewswire-FirstCall/ -- First Quarter 2009 Highlights: -- Revenue of $101.4 million, comparable year-over-year and up 6.8% on a constant currency basis --
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 
BULLS: REASONS TO BUY
Bulls: Reasons To Buy
Feeling Bullish? Be the first to explain why this would make a good investment
See All (0)
BEARS: REASONS TO SELL
Bears: Reasons To Sell
Feeling Bearish? Be the first to explain why this would make a poor investment
See All (0)
 
TOP CONTRIBUTORS
SMA AT A GLANCE
 
 
 
 
 
 
 
 
Please install Flash Player to view this chart.

Symmetry Medical, Inc., headquartered in Warsaw, Indiana, went public in December 2004 but was established in 1976 as an instruments supplier to orthopedic device manufacturers. In 1996, Symmetry acquired a manufacturer of cases to extend its product offerings. In 1998 and 1999, the company expanded its overseas presence by acquiring a UK instruments manufacturer and a cases manufacturer in France. In 2003, the company acquired Mettis (UK) Limited, a leading manufacturer of forged, cast and machined implants. The company is now the world's largest independent provider of implants and related instruments and cases to orthopedic device manufacturers. The company also designs, develops, and produces these products for companies in other segments of the medical device market, including dental, osteobiologic, and endoscopy sectors, and provides limited specialized products and services to non-healthcare markets, such as the aerospace market. The company provides its customers with a broad range of products, comprehensive services, and production capabilities through its Total Solutions approach. Symmetry Medical derives its revenue principally from four segments: implants, instruments, cases, and other products and services. The company provides implants for use in specific implant systems, mainly in knee and hip implants. Orthopedic implants are used in reconstructive surgeries to replace or repair hips, knees, and other joints, primarily shoulders, ankles, and elbows. Symmetry Medical also manufactures implant products for trauma, spine, and other implant systems. The company makes precision surgical instruments used in hip, knee, and shoulder reconstruction procedures, and in spinal, trauma, and other implant procedures. It also provides implant-specific and procedure-specific instruments. The company also produces plastic, metal, and hybrid cases to store, transport, and arrange surgical instruments and related implant systems for orthopedic device manufacturers. Dental cases are used in dental implant and general dental procedures. Other cases are used for arthroscopy, osteobiologic, endoscopy, cardiovascular, ophthalmology, and diagnostic imaging, as well as ear, nose, and throat procedures. In Q406, net revenues were $58.5 million, with implants, instruments, cases, and other products and services contributing 40%, 22%, 25%, and 13%, respectively. The company markets its Total Solutions approach through its experienced sales force that operates in the United States, Europe, and Japan. Geographically, in Q406, the United States, United Kingdom, and others contributed 58%, 22%, and 20% respectively.



[edit] References

 
Worried about pump and dump?
We review changes
for stock spam
Want to make Wikinvest better?
We need your help,
contribute today
Do you write software?
We are recruiting
the best engineers
Like Wikinvest?
Spread the word —
Tell your friends!
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki